Accenture plc (NYSE:ACN) investors are having a rough year, with the shares down more than 25%. Now Wall Street is divided over the company’s outlook.
Morgan Stanley raised its price target on Accenture to $175 from $130 on September 14. Accenture shares soared more than 6% in afternoon trading following the price target increase, even though the firm reiterated its Equal weight rating on the stock.
Meanwhile, UBS recently maintained a Buy rating on the stock with a price target of $275. The bank pointed to confidence in the company’s positioning around AI and, in separate notes, its acquisition strategy. However, Wells Fargo downgraded Accenture to Equal Weight. According to Wells Fargo, macroeconomic pressures could weigh on fiscal 2027 growth expectations.
The question is whether Accenture’s expanding AI capabilities and acquisitions can translate into long-term growth.
AI Gives Accenture a Potential Growth Engine
Accenture’s AI fortunes are tied to enterprise deployment of the technology. The company has formed a joint business group with Google Cloud to deploy AI engineers across enterprise clients. That arrangement gives Accenture another channel through which AI adoption can create demand for consulting, implementation, and integration services.
Acquisitions provide another growth engine. By adding specialized capabilities, Accenture can expand its addressable market and strengthen its ability to handle complex AI projects.
The Real Test Is Fiscal 2027 Growth
The bull case depends on Accenture converting AI adoption into revenue growth at a time when macroeconomic conditions are a concern. Wells Fargo’s warning is important because fiscal 2027 growth results could become the market’s primary test of whether Accenture’s expanding AI opportunity is translating into actual business.
The risk is that enterprises delay discretionary technology spending. At the same time, some AI applications could reduce demand for traditional technology services. That could lead to Accenture losing existing contracts faster than it can replace them with AI opportunities.
If acquisitions and AI capabilities stimulate strong demand, Accenture could be on a clear course to regain the growth profile that the market has previously rewarded. If growth remains subdued, the heavy investment in AI capabilities and acquisitions would be hard to justify.
Investors Are Positioning for a Growth Recovery
According to Insider Monkey’s database, the number of hedge funds holding Accenture rose to 69 in Q2 from 64 in Q1. Pzena Investment Management, the largest hedge fund holder, increased its stake 114% to more than 5.1 million shares. That followed an 84% increase in Q1 and 287% in Q4.
Other major funds have also been increasing exposure to Accenture. AQR Capital Management increased its position 245% to roughly 3.7 million shares to become the second-largest holder. Greenhaven Associates established a new position of around 3.4 million shares, making it the third-largest hedge fund holder.
But investor positioning is not uniformly bullish. The short interest in Accenture rose almost 9% from the previous reading to 3.81% of the public float as of August 31. With five days to cover, the short interest points to growing bearish positioning.
AI and acquisitions provide credible growth opportunities for Accenture. The investment case now rests on execution.
READ NEXT: Northrop Grumman (NOC) Secures $4.8 Billion Army Contract. Execution Is the Bigger Test and Pentagon Adds $13.4 Billion to Boeing (BA) Contract. That Isn’t an Immediate Financial Windfall.
